Video information:

In this Eye to Eye, hear how the pathology of endophthalmitis affects vitreoretinal surgeons. The novel adjuvant therapeutics now in development will be discussed and the future direction of endophthalmitis research examined.

Jan van Meurs MD, vitreoretinal surgeon at the Rotterdam Eye Hospital, the Netherlands talks with Michelle Callegan PhD, Director of Vision Research, Department of Ophthalmology, Dean McGee Eye Institute, Oklahoma, USA


Videos like Jan van Meurs and Michelle Callegan talk about EndophthalmitisRelated Videos:

Subscribe to instant updates:Keep up to date with all the latest EURETINA multimedia content
© European Society of Retina Specialists (EURETINA) 2021
Loading please wait